Walleye Trading
TEVA icon

Walleye Trading’s Teva Pharmaceuticals TEVA Stock Holding History

Walleye Trading’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$77.3M Buy
2,567,200
+1,664,400
+184% +$53.5M 0.13% 145
2025
Q4 		$28.2M Sell
902,800
-554,000
-38% -$13.6M 0.04% 472
2025
Q3 		$29.4M Sell
1,456,800
-451,500
-24% -$7.93M 0.04% 434
2025
Q2 		$32M Buy
1,908,300
+1,369,600
+254% +$22.1M 0.06% 358
2025
Q1 		$8.28M Sell
538,700
-498,300
-48% -$8.9M 0.02% 831
2024
Q4 		$22.9M Buy
1,037,000
+291,200
+39% +$5.3M 0.05% 431
2024
Q3 		$13.4M Sell
745,800
-1,034,400
-58% -$18.1M 0.03% 631
2024
Q2 		$28.9M Buy
1,780,200
+1,330,800
+296% +$20.5M 0.07% 299
2024
Q1 		$6.34M Buy
449,400
+315,400
+235% +$3.98M 0.01% 982
2023
Q4 		$1.4M Sell
134,000
-176,400
-57% -$1.65M ﹤0.01% 2201
2023
Q3 		$3.17M Buy
310,400
+107,500
+53% +$1M 0.01% 1426
2023
Q2 		$1.53M Sell
202,900
-162,800
-45% -$1.32M ﹤0.01% 1854
2023
Q1 		$3.24M Buy
365,700
+193,400
+112% +$1.91M 0.01% 1363
2022
Q4 		$1.57M Sell
172,300
-156,400
-48% -$1.36M ﹤0.01% 1872
2022
Q3 		$2.65M Sell
328,700
-116,500
-26% -$1.03M 0.01% 1487
2022
Q2 		$3.35M Sell
445,200
-211,600
-32% -$1.84M 0.01% 1276
2022
Q1 		$6.17M Buy
656,800
+450,900
+219% +$3.76M 0.02% 880
2021
Q4 		$1.65M Buy
205,900
+76,200
+59% +$688K 0.01% 1806
2021
Q3 		$1.26M Sell
129,700
-62,400
-32% -$584K ﹤0.01% 1982
2021
Q2 		$1.9M Buy
192,100
+6,800
+4% +$72K 0.01% 1545
2021
Q1 		$2.14M Sell
185,300
-30,700
-14% -$352K 0.01% 1274
2020
Q4 		$2.08M Sell
216,000
-642,700
-75% -$6.16M 0.01% 1361
2020
Q3 		$7.74M Buy
858,700
+430,900
+101% +$4.56M 0.04% 377
2020
Q2 		$5.28M Buy
427,800
+88,600
+26% +$1M 0.03% 509
2020
Q1 		$3.05M Sell
339,200
-252,700
-43% -$2.59M 0.02% 601
2019
Q4 		$5.8M Buy
591,900
+395,200
+201% +$3.53M 0.04% 499
2019
Q3 		$1.35M Buy
196,700
+10,900
+6% +$83.5K 0.01% 1373
2019
Q2 		$1.72M Sell
185,800
-713,900
-79% -$8.61M 0.01% 1166
2019
Q1 		$14.1M Sell
899,700
-88,500
-9% -$1.56M 0.11% 160
2018
Q4 		$15.2M Buy
988,200
+302,700
+44% +$6.21M 0.11% 144
2018
Q3 		$14.8M Sell
685,500
-286,500
-29% -$6.65M 0.08% 210
2018
Q2 		$23.6M Sell
972,000
-446,700
-31% -$9.11M 0.13% 110
2018
Q1 		$24.2M Buy
1,418,700
+1,077,200
+315% +$21M 0.14% 85
2017
Q4 		$6.47K Buy
341,500
+71,200
+26% +$1.07M 0.03% 539
2017
Q3 		$4.76K Sell
270,300
-34,200
-11% -$770K 0.02% 694
2017
Q2 		$10.1K Sell
304,500
-191,700
-39% -$5.93M 0.06% 292
2017
Q1 		$15.9K Buy
496,200
+208,000
+72% +$7.1M 0.11% 123
2016
Q4 		$10.5M Buy
288,200
+15,200
+6% +$607K 0.07% 187
2016
Q3 		$12.6M Buy
273,000
+171,600
+169% +$8.95M 0.08% 133
2016
Q2 		$5.09M Buy
101,400
+14,900
+17% +$793K 0.03% 442
2016
Q1 		$4.63M Sell
86,500
-190,600
-69% -$11.2M 0.04% 421
2015
Q4 		$18.2M Sell
277,100
-32,000
-10% -$1.98M 0.18% 93
2015
Q3 		$17.5M Sell
309,100
-219,300
-42% -$14.2M 0.16% 88
2015
Q2 		$31.2M Buy
528,400
+425,300
+413% +$26.2M 0.31% 38
2015
Q1 		$6.42M Sell
103,100
-160,000
-61% -$9.3M 0.06% 243
2014
Q4 		$15.1M Buy
263,100
+212,100
+416% +$11.8M 0.14% 93
2014
Q3 		$2.74M Buy
51,000
+25,400
+99% +$1.35M 0.03% 305
2014
Q2 		$1.34K Buy
25,600
+4,100
+19% +$210K 0.02% 634
2014
Q1 		$1.14K Sell
21,500
-38,700
-64% -$1.79M 0.02% 777
2013
Q4 		$2.41M Buy
60,200
+15,000
+33% +$591K 0.02% 580
2013
Q3 		$1.71M Sell
45,200
-100
-0.2% -$3.9K 0.02% 610
2013
Q2 		$1.78M Buy
+45,300
New +$1.76M 0.02% 631

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's TEVA Position: Q1 2026 in Review

Walleye Trading reduced its Teva Pharmaceuticals (TEVA) stake by 6.3% in Q1 2026, selling an estimated $1.08M and leaving 499,536 shares worth $15M. The position accounts for 0.03% of the portfolio, ranked #617.

Walleye Trading first reported a position in TEVA in Q2 2013 and has held it in 32 quarters since. The position peaked at $22M in Q3 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Walleye Trading held 499,536 shares of Teva Pharmaceuticals worth $15M as of Q1 2026.
  • Walleye Trading sold 33,426 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.08M.
  • Teva Pharmaceuticals made up 0.03% of Walleye Trading's portfolio in Q1 2026, its #617 holding.
  • Walleye Trading first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Walleye Trading's Teva Pharmaceuticals position peaked at $22M in Q3 2025.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.